Elevance Health Inc. Stock News

Besides Wall Street's top -and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during

Elevance Health (ELV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elevance Health's (ELV) brand, Anthem Blue Cross and Blue Shield, collaborates to make the benefits of Piedmont's healthcare network available to its members across specific Georgia regions.

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with the better value

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2024 financial results on April 18, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review t

Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

It will be prudent to invest in non-technology stocks with a favorable Zacks Rank to gain in the near future. Five such stocks are: WELL, GIS, ELV, RCL, RYAAY.

CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.

The rate adds more pressure on insurers already grappling with high medical costs and uncertainty after the cyberattack on UnitedHealth Group's tech unit.

Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.

UnitedHealth, Humana and other big health insurers fell Monday night on lower-than-expected Medicare Advantage rates for 2025.

The SPDR S&P 500 ETF Trust had a 3.27% return in March, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares. The top 15 dividend growth stocks for April 2024 offer an average dividend

Some large health insurers in the U.S. will start covering Wegovy, which has become a popular anti-obesity drug — but not for those using it to lose weight, according to a report by The Wall Street

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with t

Grocery-store chain  Kroger (KR) is selling its specialty pharmacy business to U.S. health insurer Elevance Health (ELV).